Therefore, the in vivo data are highly concordant with the in vitro outcomes and support that Alisol B regulated RARα-PPARγ-CD36 cascade and further alleviated the phenotypes of NASH. Here, CD36 is linked to metabolic dysfunction-associated steatohepatitis.